Efficacy of daily single dose rifaximin for the prevention of hepatic encephalopathy in liver cirrhosis patients as compared to twice daily dosing.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Rifaximin (Primary)
- Indications Hepatic encephalopathy
- Focus Therapeutic Use
- 15 Dec 2015 New trial record